Skip to main content
SpringerLink
Log in

Esophageal Cancer

  • Reference work entry
  • First Online:
Geriatric Gastroenterology

  • 137 Accesses

Abstract

The epidemiology of esophageal cancer has marked variations in different areas of the world. The two major types are squamous cell carcinoma and adenocarcinoma; the latter entity has attracted much attention because of increasing prevalence in the Western nations. The major risk factors for adenocarcinoma include long-standing gastroesophageal reflux disease, Barrett’s metaplasia, and obesity. Risk factors for squamous cell carcinoma include alcoholism and smoking. Manifestations include dysphagia to solids and liquids, weight loss, and aspiration. Diagnosis requires upper endoscopy and target biopsies. Staging requires endoscopic ultrasound and CT imaging of chest and abdomen. Management includes surgery, chemotherapy, and radiation, based on location, stage, and type of cancer, in addition to consideration for age and comorbidities. New options for systemic therapy include targeted therapies and immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Abnet CC, et al. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst. 2005;97(4):301–6.

    Article  CAS  PubMed  Google Scholar 

  • Abnet CC, et al. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer. 2008;44(3):465–71.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ajani JA, et al. Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 study group. J Clin Oncol. 2007;25(22):3205–9.

    Article  CAS  PubMed  Google Scholar 

  • Akhtar S, Sheikh AA, Qureshi HU. Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in south Asians: a multicentre case-control study. Eur J Cancer. 2012;48(5):655–61.

    Article  PubMed  Google Scholar 

  • Al-Batran SE, et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol. 2008;26(9):1435–42.

    Article  CAS  PubMed  Google Scholar 

  • Al-Batran S-E, et al. Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): a multicenter, randomized phase 3 trial. J Clin Oncol. 2017;35:4004.

    Article  Google Scholar 

  • Allum WH, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27(30):5062–7.

    Article  PubMed  Google Scholar 

  • al-Sarraf M, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997;15(1):277–84.

    Article  CAS  PubMed  Google Scholar 

  • Amin MB, Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. Cham: Springer; 2017. xvii, 1024 pages.

    Book  Google Scholar 

  • Arnold M, et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247–55.

    Article  PubMed  Google Scholar 

  • Balducci L. Systemic treatment of gastric and esophageal adenocarcinoma in elderly patients. J Gastrointest Oncol. 2015;6(1):75–8.

    PubMed  PubMed Central  Google Scholar 

  • Bang YJ, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687–97.

    Article  CAS  PubMed  Google Scholar 

  • Baquet CR, et al. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc. 2005;97(11):1471–8.

    PubMed  PubMed Central  Google Scholar 

  • Barreto JC, Posner MC. Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol. 2010;16(30):3804–10.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bergman JJ, et al. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc. 2011;74(6):1181–90.

    Article  PubMed  PubMed Central  Google Scholar 

  • Berry MF, et al. Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection. J Thorac Oncol. 2013;8(6):796–802.

    Article  PubMed  PubMed Central  Google Scholar 

  • Blaydon DC, et al. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Am J Hum Genet. 2012;90(2):340–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bleiberg H, et al. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer. 1997;33(8):1216–20.

    Article  CAS  PubMed  Google Scholar 

  • Bravi F, et al. Dietary patterns and the risk of esophageal cancer. Ann Oncol. 2012;23(3):765–70.

    Article  CAS  PubMed  Google Scholar 

  • Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  PubMed  Google Scholar 

  • Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002;11(2):235–56.

    Article  PubMed  Google Scholar 

  • Burkart C, et al. A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancer. Anticancer Res. 2007;27(4C):2845–8.

    CAS  PubMed  Google Scholar 

  • Chang AC, et al. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg. 2008;85(2):424–9.

    Article  PubMed  Google Scholar 

  • Chen ZM, et al. Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. JAMA. 1997;278(18):1500–4.

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, et al. Incidence and survival differences in esophageal cancer among ethnic groups in the United States. Oncotarget. 2017;8(29):47037–51.

    Article  PubMed  PubMed Central  Google Scholar 

  • Choi YJ, et al. The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population-based cohort study of South Korea. PLoS One. 2017;12(10):e0185778.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chu FS, Li GY. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People’s Republic of China in regions with high incidences of esophageal cancer. Appl Environ Microbiol. 1994;60(3):847–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coleman HG, et al. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol. 2011;26(9):739–45.

    Article  PubMed  Google Scholar 

  • Cook MB, et al. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett’s esophagus. Am J Gastroenterol. 2008;103(2):292–300.

    Article  PubMed  Google Scholar 

  • Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br J Cancer. 2009;101(5):855–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cook MB, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102(17):1344–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cook MB, et al. Cancer incidence and mortality risks in a large US Barrett’s oesophagus cohort. Gut. 2018;67(3):418–529.

    Article  PubMed  Google Scholar 

  • Cross AJ, et al. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol. 2011;106(3):432–42.

    Article  CAS  PubMed  Google Scholar 

  • Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

    Article  CAS  PubMed  Google Scholar 

  • Daly JM, Karnell LH, Menck HR. National cancer data base report on esophageal carcinoma. Cancer. 1996;78(8):1820–8.

    Article  CAS  PubMed  Google Scholar 

  • Daly JM, et al. Esophageal cancer: results of an American College of surgeons patient care evaluation study. J Am Coll Surg. 2000;190(5):562–72; discussion 572–3.

    Article  CAS  PubMed  Google Scholar 

  • DaVee T, Ajani JA, Lee JH. Is endoscopic ultrasound examination necessary in the management of esophageal cancer? World J Gastroenterol. 2017;23(5):751–62.

    Article  PubMed  PubMed Central  Google Scholar 

  • de Jonge PJ, et al. Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63(1):191–202.

    Article  PubMed  Google Scholar 

  • Donohoe CL, Reynolds JV. Neoadjuvant treatment of locally advanced esophageal and junctional cancer: the evidence-base, current key questions and clinical trials. J Thorac Dis. 2017;9(Suppl 8):S697–704.

    Article  PubMed  PubMed Central  Google Scholar 

  • Druesne-Pecollo N, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol. 2009;10(2):173–80.

    Article  CAS  PubMed  Google Scholar 

  • Du X, Hidayat K, Shi BM. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep. 2017;37(3):BSR20160474

    Google Scholar 

  • Dubecz A, et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol. 2012;7(2):443–7.

    Article  PubMed  Google Scholar 

  • Einzig AI, et al. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the eastern cooperative oncology group (ECOG) results of protocol E1293. Med Oncol. 1996;13(2):87–93.

    Article  CAS  PubMed  Google Scholar 

  • Ell C, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000;118(4):670–7.

    Article  CAS  PubMed  Google Scholar 

  • Elsayed H, et al. The influence of age on mortality and survival in patients undergoing oesophagogastrectomies. A seven-year experience in a tertiary Centre. Interact Cardiovasc Thorac Surg. 2010;11(1):65–9.

    Article  PubMed  Google Scholar 

  • Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.

    Article  CAS  PubMed  Google Scholar 

  • Enzinger PC, et al. CALGB 80403 (Alliance)/E1206: a randomized phase II study of three chemotherapy regimens plus cetuximab in metastatic esophageal and gastroesophageal junction cancers. J Clin Oncol. 2016;34(23):2736–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ezdinli EZ, et al. Chemotherapy of advanced esophageal carcinoma: eastern cooperative oncology group experience. Cancer. 1980;46(10):2149–53.

    Article  CAS  PubMed  Google Scholar 

  • Fielding RA, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.

    Article  PubMed  Google Scholar 

  • Findlay M, et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol. 1994;5(7):609–16.

    Article  CAS  PubMed  Google Scholar 

  • Freedman ND, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424–33.

    Article  PubMed  Google Scholar 

  • Freedman ND, et al. Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH-AARP cohort. Int J Epidemiol. 2016;45(3):846–56.

    Article  PubMed  Google Scholar 

  • Fuchs CS, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383(9911):31–9.

    Article  CAS  PubMed  Google Scholar 

  • Fuchs CS, et al. Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial. JAMA Oncol. 2018;4(5):e180013.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gatenby P, et al. Risk stratification for malignant progression in Barrett’s esophagus: gender, age, duration and year of surveillance. World J Gastroenterol. 2016;22(48):10592–600.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gerger A, LaBonte M, Lenz HJ. Molecular predictors of response to antiangiogenesis therapies. Cancer J. 2011;17(2):134–41.

    Article  CAS  PubMed  Google Scholar 

  • Gholipour C, Shalchi RA, Abbasi M. A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus. 2008;21(4):322–7.

    Article  CAS  PubMed  Google Scholar 

  • Goldblum JR. Barrett’s esophagus and Barrett’s-related dysplasia. Mod Pathol. 2003;16(4):316–24.

    Article  PubMed  Google Scholar 

  • Gowryshankar A, Nagaraja V, Eslick GD. HER2 status in Barrett’s esophagus & esophageal cancer: a meta analysis. J Gastrointest Oncol. 2014;5(1):25–35.

    PubMed  PubMed Central  Google Scholar 

  • Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19(9):1523–9.

    Article  CAS  PubMed  Google Scholar 

  • Gross SA, Raimondo M, Conio M. Upper gastrointestinal tumors. Endoscopy. 2007;39(2):110–2.

    Article  CAS  PubMed  Google Scholar 

  • Gustavsson P, et al. Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: a case-control study in Sweden. Occup Environ Med. 1998;55(6):393–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.

    Article  PubMed  Google Scholar 

  • He S, et al. Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial. Endoscopy. 2015;47(5):398–408.

    Article  PubMed  PubMed Central  Google Scholar 

  • Herskovic A, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326(24):1593–8.

    Article  CAS  PubMed  Google Scholar 

  • Honoré C, et al. Esophageal cancer surgery in patients older than 75: long term results. Acta Chir Belg. 2011;111(1):12–7.

    Article  PubMed  Google Scholar 

  • Hosch SB, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol. 2001;19(7):1970–5.

    Article  CAS  PubMed  Google Scholar 

  • Hoyo C, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium. Int J Epidemiol. 2012;41(6):1706–18.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hurria A, et al. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(1):82–126.

    Article  Google Scholar 

  • Ilhan M, et al. Palmoplantar keratoderma is associated with esophagus squamous cell cancer in Van region of Turkey: a case control study. BMC Cancer. 2005;5:90.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ilson DH, et al. Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer. Ann Oncol. 2007;18(5):898–902.

    Article  CAS  PubMed  Google Scholar 

  • Inadomi JM, Saxena N. Screening and surveillance for Barrett’s esophagus: is it cost-effective? Dig Dis Sci. 2018;63(8):2094–104.

    Article  PubMed  Google Scholar 

  • Iribarren C, et al. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med. 1999;340(23):1773–80.

    Article  CAS  PubMed  Google Scholar 

  • Islami F, et al. High-temperature beverages and foods and esophageal cancer risk – a systematic review. Int J Cancer. 2009a;125(3):491–524.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Islami F, et al. Pickled vegetables and the risk of oesophageal cancer: a meta-analysis. Br J Cancer. 2009b;101(9):1641–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Islami F, et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer. 2011;129(10):2473–84.

    Article  CAS  PubMed  Google Scholar 

  • Islami F, et al. A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma. Int J Cancer. 2020;146(1):18–25.

    Google Scholar 

  • Isolauri J, Markkula H. Lye ingestion and carcinoma of the esophagus. Acta Chir Scand. 1989;155(4–5):269–71.

    CAS  PubMed  Google Scholar 

  • Janjigian YY, Shah MA. Molecularly targeted therapies in advanced gastric cancer. Minerva Gastroenterol Dietol. 2011;57(1):75–88.

    CAS  PubMed  Google Scholar 

  • Janjigian YY, et al. First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA). J Clin Oncol. 2019;37:62.

    Article  Google Scholar 

  • Janmaat VT, et al. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063.

    PubMed  Google Scholar 

  • Jatoi A, et al. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive north central cancer treatment group (NCCTG) trials. Int J Oncol. 2010;36(3):601–6.

    Article  CAS  PubMed  Google Scholar 

  • Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  • Jiang JM, et al. Smoking and mortality from esophageal cancer in China: a large case-control study of 19,734 male esophageal cancer deaths and 104,846 living spouse controls. Int J Cancer. 2006;119(6):1427–32.

    Article  CAS  PubMed  Google Scholar 

  • Jung KW, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett’s esophagus: a population-based study. Am J Gastroenterol. 2011;106(8):1447–55; quiz 1456.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kamangar F, et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009;38(1):27–57, vii.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kang YK, et al. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol. 2009;20(4):666–73.

    Article  PubMed  Google Scholar 

  • Kato H, et al. Intramural metastasis of thoracic esophageal carcinoma. Int J Cancer. 1992;50(1):49–52.

    Article  CAS  PubMed  Google Scholar 

  • Kelsen DP, et al. Long-term results of RTOG trial 8911 (USA intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25(24):3719–25.

    Article  PubMed  Google Scholar 

  • Koëter M, et al. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival. Acta Oncol. 2018;57(9):1192–200.

    Article  PubMed  Google Scholar 

  • Kojima T, et al. Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase III KEYNOTE-181 study. J Clin Oncol. 2019;37:2.

    Article  Google Scholar 

  • Kok TC, van der Gaast A, Splinter TA. 5-fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area. Rotterdam esophageal tumor study group. Ann Oncol. 1996;7(5):533–4.

    Article  CAS  PubMed  Google Scholar 

  • Kuipers EJ, Haringsma J. Diagnostic and therapeutic endoscopy. J Surg Oncol. 2005;92(3):203–9.

    Article  CAS  PubMed  Google Scholar 

  • Lange M, et al. Decline in cognitive function in older adults with early-stage breast cancer after adjuvant treatment. Oncologist. 2016;21(11):1337–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology. 2006;131(4):1271–83.

    Article  CAS  PubMed  Google Scholar 

  • Le DT, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Le DT, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lepage C, et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008;103(11):2694–9.

    Article  PubMed  Google Scholar 

  • Lester SC, et al. A multi-institutional analysis of Trimodality therapy for Esophageal Cancer in elderly patients. Int J Radiat Oncol Biol Phys. 2017;98(4):820–8.

    Article  PubMed  Google Scholar 

  • Lightdale CJ, Kulkarni KG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol. 2005;23(20):4483–9.

    Article  PubMed  Google Scholar 

  • Liu J, et al. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013;133(2):473–85.

    Article  CAS  PubMed  Google Scholar 

  • Lu CL, et al. Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan. Cancer Causes Control. 2010;21(2):269–74.

    Article  PubMed  Google Scholar 

  • Madhusudhan C, et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus. 2009;22(4):331–6.

    Article  PubMed  Google Scholar 

  • Mathieu LN, et al. Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2008). Dis Esophagus. 2014;27(8):757–63.

    Article  CAS  PubMed  Google Scholar 

  • Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727–33.

    Article  Google Scholar 

  • Miyata H, et al. Clinical outcome of esophagectomy in elderly patients with and without neoadjuvant therapy for thoracic esophageal cancer. Ann Surg Oncol. 2015;22(Suppl 3):S794–801.

    Article  PubMed  Google Scholar 

  • Morganstern B, Anandasabapathy S. GERD and Barrett’s esophagus: diagnostic and management strategies in the geriatric population. Geriatrics. 2009;64(7):9–12.

    PubMed  Google Scholar 

  • Morita M, et al. Advances in esophageal surgery in elderly patients with thoracic esophageal cancer. Anticancer Res. 2013;33(4):1641–7.

    PubMed  Google Scholar 

  • Muro K, et al. A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol. 2004;15(6):955–9.

    Article  CAS  PubMed  Google Scholar 

  • Muro K, et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol. 2016;17(6):717–26.

    Article  CAS  PubMed  Google Scholar 

  • Navarro Silvera SA, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer. 2008;123(4):852–60.

    Article  PubMed  CAS  Google Scholar 

  • Nigro JJ, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg. 1999;117(1):16–23; discussion 23–5.

    Article  CAS  PubMed  Google Scholar 

  • NIH. Cancer stat facts: esophageal cancer. 2019. https://seer.cancer.gov/statfacts/html/esoph.html. Accessed 8 Mar 2019.

  • Nordenstedt H, El-Serag H. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992–2006). Scand J Gastroenterol. 2011;46(5):597–602.

    Article  PubMed  Google Scholar 

  • O’Doherty MG, et al. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP diet and health study. Gut. 2012;61(9):1261–8.

    Article  PubMed  Google Scholar 

  • Okines AF, et al. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann Oncol. 2009;20(9):1529–34.

    Article  CAS  PubMed  Google Scholar 

  • Pandeya N, et al. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol. 2008;168(1):105–14.

    Article  PubMed  Google Scholar 

  • Pandeya N, et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136(4):1215–24, e1–2.

    Article  CAS  PubMed  Google Scholar 

  • Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parent ME, Siemiatycki J, Fritschi L. Workplace exposures and oesophageal cancer. Occup Environ Med. 2000;57(5):325–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pech O, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–660.e1.

    Article  PubMed  Google Scholar 

  • Pickwell SM, Schimelpfening S, Palinkas LA. ‘Betelmania’. Betel quid chewing by Cambodian women in the United States and its potential health effects. West J Med. 1994;160(4):326–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomark Prev. 2010;19(6):1468–70.

    Article  Google Scholar 

  • Pottern LM, et al. Esophageal cancer among black men in Washington, D.C. I. Alcohol, tobacco, and other risk factors. J Natl Cancer Inst. 1981;67(4):777–83.

    CAS  PubMed  Google Scholar 

  • Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109(6):822–7.

    Article  PubMed  Google Scholar 

  • Press MF, et al. HER2 status in advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma for entry to the TRIO-013/LOGiC trial of Lapatinib. Mol Cancer Ther. 2017;16(1):228–38.

    Article  CAS  PubMed  Google Scholar 

  • Puli SR, et al. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14(10):1479–90.

    Article  PubMed  PubMed Central  Google Scholar 

  • Randi G, et al. Pipe smoking and cancers of the upper digestive tract. Int J Cancer. 2007;121(9):2049–51.

    Article  CAS  PubMed  Google Scholar 

  • Rasool S, et al. Esophageal cancer: associated factors with special reference to the Kashmir Valley. Tumori. 2012;98(2):191–203.

    Article  CAS  PubMed  Google Scholar 

  • Rastogi A, et al. Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008;67(3):394–8.

    Article  PubMed  Google Scholar 

  • Rex DK, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125(6):1670–7.

    Article  PubMed  Google Scholar 

  • Rice TW, et al. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016a;29(8):913–9.

    Article  PubMed  Google Scholar 

  • Rice TW, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016b;29(8):897–905.

    Article  CAS  PubMed  Google Scholar 

  • Riedel M, et al. Preoperative bronchoscopic assessment of airway invasion by esophageal cancer: a prospective study. Chest. 1998;113(3):687–95.

    Article  CAS  PubMed  Google Scholar 

  • Ronkainen J, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.

    Article  PubMed  Google Scholar 

  • Sandler RS, et al. The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA. 1995;274(17):1359–62.

    Article  CAS  PubMed  Google Scholar 

  • Santibañez M, et al. Occupational exposures and risk of oesophageal cancer by histological type: a case-control study in eastern Spain. Occup Environ Med. 2008;65(11):774–81.

    Article  PubMed  Google Scholar 

  • Schatz RA, Rockey DC. Gastrointestinal bleeding due to gastrointestinal tract malignancy: natural history, management, and outcomes. Dig Dis Sci. 2017;62(2):491–501.

    Article  PubMed  Google Scholar 

  • Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review. World J Gastroenterol. 2013;19(9):1424–37.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shaheen NJ, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30–50; quiz 51.

    Article  CAS  PubMed  Google Scholar 

  • Shakhatreh MH, et al. The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett’s esophagus. Am J Gastroenterol. 2014;109(12):1862–8; quiz 1861, 1869.

    Article  PubMed  Google Scholar 

  • Shapiro J, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8.

    Article  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  PubMed  Google Scholar 

  • Soubeyran P, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol. 2012;30(15):1829–34.

    Article  PubMed  Google Scholar 

  • Spechler SJ, Barr H. Review article: screening and surveillance of Barrett’s oesophagus: what is a cost-effective framework? Aliment Pharmacol Ther. 2004;19(Suppl 1):49–53.

    Article  PubMed  Google Scholar 

  • Stachler MD, et al. Paired exome analysis of Barrett’s esophagus and adenocarcinoma. Nat Genet. 2015;47(9):1047–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steevens J, et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2010a;22(6):669–78.

    PubMed  Google Scholar 

  • Steevens J, et al. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology. 2010b;138(5):1704–13.

    Article  CAS  PubMed  Google Scholar 

  • Steffen A, et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer. 2015;137(3):646–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stevens HP, et al. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol. 1996;132(6):640–51.

    Article  CAS  PubMed  Google Scholar 

  • Sung H, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69(2):88–112.

    PubMed  Google Scholar 

  • Tachimori Y, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24(1):33–8.

    Article  CAS  PubMed  Google Scholar 

  • Tepper J, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086–92.

    Article  CAS  PubMed  Google Scholar 

  • Thrift AP. The epidemic of oesophageal carcinoma: where are we now? Cancer Epidemiol. 2016;41:88–95.

    Article  PubMed  Google Scholar 

  • Torre LA, et al. Global cancer incidence and mortality rates and trends – an update. Cancer Epidemiol Biomark Prev. 2016;25(1):16–27.

    Article  Google Scholar 

  • Torres-Aguilera M, Remes Troche JM. Achalasia and esophageal cancer: risks and links. Clin Exp Gastroenterol. 2018;11:309–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tougeron D, et al. Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 2010;10:510.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tramontano AC, et al. Hospice use and end-of-life care among older patients with esophageal cancer. Health Sci Rep. 2018;1(9):e76.

    Article  PubMed  PubMed Central  Google Scholar 

  • Trivedy C, et al. Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet. 1997;349(9063):1447.

    Article  CAS  PubMed  Google Scholar 

  • Van der Veen AH, et al. Adenocarcinoma in Barrett’s oesophagus: an overrated risk. Gut. 1989;30(1):14–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • van Deudekom FJ, et al. Functional and cognitive impairment, social functioning, frailty and adverse health outcomes in older patients with esophageal cancer, a systematic review. J Geriatr Oncol. 2018;9(6):560–8.

    Article  PubMed  Google Scholar 

  • van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.

    Article  PubMed  Google Scholar 

  • van Soest EM, et al. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54(8):1062–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • van Vliet EP, et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547–57.

    Article  PubMed  PubMed Central  Google Scholar 

  • Vingeliene S, et al. An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk. Ann Oncol. 2017;28(10):2409–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vlacich G, et al. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database. Cancer Med. 2017;6(12):2886–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang L, et al. Mutations of O6-methylguanine-DNA methyltransferase gene in esophageal cancer tissues from northern China. Int J Cancer. 1997;71(5):719–23.

    Article  CAS  PubMed  Google Scholar 

  • Ward EM, et al. Barrett’s esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol. 2006;101(1):12–7.

    Article  PubMed  Google Scholar 

  • Warner E, et al. Outpatient 5-fluorouracil, folinic acid and cisplatin in patients with advanced esophageal carcinoma. Acta Oncol. 1999;38(2):255–9.

    Article  CAS  PubMed  Google Scholar 

  • Wilke H, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15(11):1224–35.

    Article  CAS  PubMed  Google Scholar 

  • Włodarczyk JR, Kużdżał J. Stenting in palliation of unresectable esophageal cancer. World J Surg. 2018;42(12):3988–96.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wobbes T, et al. Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer. 2001;37(4):470–7.

    Article  CAS  PubMed  Google Scholar 

  • Won E, Ilson DH. Management of localized esophageal cancer in the older patient. Oncologist. 2014;19(4):367–74.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wu M, et al. Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer. 2009;124(8):1907–13.

    Article  CAS  PubMed  Google Scholar 

  • Wu M, et al. Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control. 2011;22(4):649–57.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yau KK, et al. Immediate preoperative laparoscopic staging for squamous cell carcinoma of the esophagus. Surg Endosc. 2006;20(2):307–10.

    Article  CAS  PubMed  Google Scholar 

  • Ychou M, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21.

    Article  CAS  PubMed  Google Scholar 

  • Yu C, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med. 2018;168(7):489–97.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zagari RM, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57(10):1354–9.

    Article  CAS  PubMed  Google Scholar 

  • Zehetner J, et al. Esophagectomy for cancer in octogenarians. Dis Esophagus. 2010;23(8):666–9.

    Article  CAS  PubMed  Google Scholar 

  • Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31(6):281–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Montefiore Medical Center, Bronx, NY, USA

    Jennifer Chuy & Noah Kornblum

Authors
  1. Jennifer Chuy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noah Kornblum
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer Chuy .

Editor information

Editors and Affiliations

  1. Department of Medicine, Robert Wood Johnson School of Medicine, Rutgers University, New Brunswick, NJ, USA

    C. S. Pitchumoni

  2. Department of Medicine, Division of Geriatrics, Montefiore Medical Center, Wakefield Campus, Bronx, NY, USA

    T.S. Dharmarajan

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Chuy, J., Kornblum, N. (2021). Esophageal Cancer. In: Pitchumoni, C.S., Dharmarajan, T. (eds) Geriatric Gastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-030-30192-7_78

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-30192-7_78

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-30191-0

  • Online ISBN: 978-3-030-30192-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation